Adaptogenics names J. David Warren CEO, adds him to board

Bitget2026/10/02 11:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Adaptogenics named J. David Warren CEO, director effective Oct. 1, 2026; Weill Cornell adjunct professor, ex-director of Milstein Chemistry Core.
Anthony Franco stepped down as CEO, director effective Oct. 1, 2026.
Gurinder Sandhu appointed executive vice president, corporate development; remains a director.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptogenics Health Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610020730NEWSFILECNPR____20261002_317007_1) on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Adaptogenics names J. David Warren CEO, adds him to board

You may also like

Crypto prices